#mosquito control rochester

[townandcountrysolutions]

Your Trusted Partner in Pest Control Across Buffalo, Rochester, and Syracuse

Dealing with mice and insects in public and private surroundings poses an uphill task for homeowners and the private sector. People at Town and Country Solutions are already aware that every area has its different requirements and, of course, Buffalo, Rochester, and Syracuse are no exception. With our trained experts at hand, be it bed bugs, flies, bees, or any other pest bothering, our solutions are always right there to deal with the most specific matters.

Commercial Pest Control in Buffalo: The Buffalo area provides a suitable environment for both the summer and winter seasons for diverse pests to dwell on commercial properties. Professional pest control services at Town and Country Solutions can completely cover your business to make it a healthy and hygienic place. Our trained and qualified staff utilizes cutting-edge technologies to exterminate and control pests. These in turn minimize the expenses and prevent your business from a bad reputation and therefore provide peace of mind to both your employees and your customers.

Bed Bug Extermination in Rochester: In recent months bed bugs have turned out to a problem for Rochester neighborhoods. The presence of insects in your life and business causes many disturbances. Town and Country Solutions undertakes projects of all kinds, from start to finish, for eliminating bedbugs. In Rochester, our specifically designed bed bug removal process employs sophisticated detection and elimination methods coming full circle and complete with re-treatments when necessary to ensure bed bugs will not reenter your premises.

Pest and Mosquito Control in Syracuse: In Syracuse, where the seasonal pests may be unpredictable not only in severity but also in adaptability, the use of the integrated pest management technique both for homeowners and business markets is very important. our service which goes beyond the common one also includes the Syracuse mosquito control service. We are devoted to the application of environmentally friendly solutions that have a proven track record for a reduction in populations of mosquitoes, contributing to a soothing environment and, therefore, making outdoor activities safe without exposure to mosquito-borne diseases.

Bee Control in Rochester: Bees are essential for the environment, but they can pose risks when nests are located too close to human activity. In Rochester, our bee control services focus on safe relocation and removal techniques. We work closely with local environmental groups to ensure that bee populations are preserved and handled humanely, protecting both your property and the ecosystem.

Managing Rochester NY Bed Bugs: It is the reappearance of bed bugs in Rochester, NY that requires a full complex of approaches and accurate control. Town And Country Solutions has built the right set of protocols in this ideology of destroying bed bugs from inspection to satisfactory clearance. Our residency and room check program helps you will need to handle pest issues minima and therefore, no distraction to your lifestyle.

T&C Solutions is a company that is dedicated to bringing the very best pest control services to Buffalo, Rochester, and Syracuse; has earned a reputation for offering industry-leading services that will address each customer’s individual needs. We demonstrate our excellence and the satisfaction of customers are one of the main factors that divides us from others in the industry. Contact us today to talk about how our pest control services can help restore comfort and safety to your home. As such, you can have a much safer place to invest in.

[mosquitoshield78]

Trust Mosquito Shield for Rochester, MA's Comprehensive Mosquito Control Solutions

Rochester, MA residents trust Mosquito Shield for all their mosquito control needs. Our time-tested solutions ensure that you can enjoy your outdoor spaces in peace. With our Mosquito Control Rochester, MA services, you can reclaim your yard, patio, and garden from the relentless mosquitoes and make the most of your leisure time.

[kb1cqx]

Weather Alerts-Wells, ME

Tornado Watch

From Sun 1:04 pm until 8:00 pm EDT

1 of 2

Action Recommended

Attend to information sources as described in the instructions

Issued By

Portland - ME, US, National Weather Service

Affected Area

York County

Description

THE NATIONAL WEATHER SERVICE HAS ISSUED TORNADO WATCH 448 IN EFFECT UNTIL 8 PM EDT THIS EVENING FOR THE FOLLOWING AREAS IN MAINE THIS WATCH INCLUDES 5 COUNTIES IN SOUTHWEST MAINE ANDROSCOGGIN CUMBERLAND YORK IN WESTERN MAINE FRANKLIN OXFORD IN NEW HAMPSHIRE THIS WATCH INCLUDES 10 COUNTIES IN CENTRAL NEW HAMPSHIRE BELKNAP MERRIMACK STRAFFORD SULLIVAN IN NORTHERN NEW HAMPSHIRE CARROLL COOS GRAFTON IN SOUTHERN NEW HAMPSHIRE CHESHIRE HILLSBOROUGH ROCKINGHAM THIS INCLUDES THE CITIES OF ALFRED, ANDOVER, ASHLAND, ATKINSON, AUBURN, AVON, BARRINGTON, BERLIN, BETHEL, BETHLEHEM, BIDDEFORD, BOSCAWEN, BRIDGEWATER, BROOKFIELD, BRYANT POND, BYRON, CANTERBURY, CAPE ELIZABETH, CHESTER, CLAREMONT, COBURN GORE, CONCORD, CORNISH, CROYDON, DAVIS, DERRY, DOVER, DUMMER, DUNBARTON, DURHAM, ERROL, FARMINGTON, GILFORD, GILSUM, GOSHEN, GRANTHAM, GREENE, HAMPSTEAD, HANOVER, HOLLIS, JACKSON, KEENE, KINGFIELD, LACONIA, LEBANON, LEBANON, LEMPSTER, LEWISTON, LINCOLN, LITTLETON, LOUDON, LYME, MADBURY, MANCHESTER, MARLOW, MILAN, MILLSFIELD, MINOT, NASHUA, NEW GLOUCESTER, NEWTON, OLD ORCHARD BEACH, OQUOSSOC, OSSIPEE, PELHAM, PLAISTOW, PORTLAND, RANGELEY, ROCHESTER, ROLLINSFORD, SABATTUS, SACO, SALEM, SANFORD, SOMERSWORTH, SOUTH PORTLAND, SUGAR HILL, SULLIVAN, SURRY, TUFTONBORO, TURNER, UNITY, UPTON, WAKEFIELD, WALES, WESTBROOK, WILSONS MILLS, WOLFEBORO, AND YORK POND.

Special Weather Statement

Until Sun 2:00 pm EDT

2 of 2

Action Recommended

Avoid the subject event as per the instructions

Issued By

Portland - ME, US, National Weather Service

Affected Area

Coastal York County

Description

...A Significant Severe Weather Event is Possible this Afternoon and Evening... Despite morning clouds and rainfall...warmer and more unstable air will push into the region through early this afternoon ahead of an advancing cold front. This will set the stage for a developing severe weather event. Thunderstorms have developed across upstate New York as of 12pm. These storms are expected to intensify and expand in coverage as they move east through the afternoon. Storms are expected to move into western New Hampshire after 2pm...reaching western Maine after 4pm. The severe weather threat should come to an end after 8pm. Storms will have the potential to produce damaging winds...large hail and isolated tornadoes. Torrential rainfall with localized flooding will also be possible. Please be alert to changing weather conditions and have a way to receive warnings from the National Weather Service.

Advertisement

Radar

Now1:45 pm2:15 pm2:45 pm3:15 pm3:45 pm4:15 pm4:45 pm5:15 pm5:45 pm6:15 pm6:45 pm7:15 pm

Advertisement

Advertisement

Inspire The Griller

How Weather Can Affect Your Grilling Experience

Grilling Safely: Tips for a Fire-Safe July 4 Cookout

How To Clean Your Grill

Embracing All Seasons: A Guide To Grilling In Rain, Wind And SnowSee More

Advertisement

Cracking Mosquito Color Code

Wear These Shades To Repeal Them

Advertisement

Safety & Preparedness

Ocean Safety 101: How To Deal With Rip Currents

You May Be Surprised To Learn How Fast A Car Heats Up

72 Hours To Safety: Your Ultimate Hurricane Prep Guide

Prescription Drugs Could Be Dangerous In Heat WavesSee More

Advertisement

Stay Safe

Advertisement

Advertisement

Connect With Us

Feedback

Mission

Careers

News Room

Advertise With Us

TV

Newsletter Sign Up

Terms of Use

Privacy Policy

AdChoices

Accessibility Statement

Data Vendors

We recognize our responsibility to use data and technology for good. We may use or share your data with our data vendors. Take control of your data.

Review All Privacy and Ad Settings

Choose how my information is shared

Data Rights

© The Weather Company, LLC 2024

[gamexterm18-blog]

What is the best season for pest to make a shelter in your home?

Pest is one of the most terrible issues faced in every home during cold atmospheric conditions. As the temperatures come down, pests will love to take shelter in warmer places. Winter is the season when pest tries to enter the house just to put themselves into warm. Thus, there comes the need of the pest control Rochester NY, to remove them and stay safe. So, it is necessary to take care, when they take up residence in homes. 

In Rochester or many areas of New York, pests will take their shelter in the home to make themselves comfortable. The most common critters that enter the home are:

Cockroaches

Rat

Mice

Ants

Spiders

Mosquitoes and other pests

Among these pests, cockroaches are the one that reproduces and sit on the food and all other things in the living space. Rats and mice are the other pests that will damage lots of the property such as wiring, gas lines and others. So, taking help from exterminator Rochester, NY is highly necessary for the winter. If the pest is not controlled, then they enter our food causing serious health issues, especially when the house is accompanied by kids and elders.

Pets cause some serious health problems. Hence, there comes the need to control by approaching pest control Rochester NY services. GAM Exterminating helps in solving pest problems by offering their services to residential and commercial properties. They take all the responsibility to offer the highest level of services for risk management, reassurance and responsiveness. They have a team of specialized professionals, trained in offering best solutions to prevent pest which are tailored to meet the specific needs of their customers.

To prevent and take care of your home, it is a better idea to approach best pest control Rochester NY services in the winter season. To know about the pest control services offered by GAM Exterminating, call or visit their website for consultation and other information.

[buggcontrol]

bee removal rochester ny - buggcontrol.com

Bugg Control, Inc. is your Rochester NY, and Buffalo bee exterminator. Our bug exterminator specializes in providing quality bee control and can also help rid you of wasps, hornets, mosquitoes, and other flying insects. We help you take back your home and protect the people in it from ants and bees. Our bee exterminator in Williamsville NY is safe and effective. We are fully insured and licensed to carry out the removal of bees from any premises. Call us today to schedule your service. Visit https://buggcontrol.com/bee-control/ for more information.

[cool-cillian-murphy]

Hemostatic Forceps Market Latest Review: Know More about Industry Gainers

Latest Research Study on Global Hemostatic Forceps Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Hemostatic Forceps Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Hemostatic Forceps. This Report also covers the emerging player’s data, including: Competitive situation, sales, revenue and global market share of top manufacturers are Medline Industries (United States), B. Braun Melsungen AG (Germany), CareFusion (United States), Asa Dental S.p.A (Italy), Sklar Corp. (United States), Scanlan International (United States), Shanghai Medical Instruments (China), Lawton (United States), J& J instruments (United States), American Diagnostics (United States).

Brief Summary of Hemostatic Forceps: The Global Hemostatic Forceps Market is driven by the increase in the number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments and rising focus on effective blood loss management in patients during surgeries. Hemostatic Forceps (also called a Hemostat) is a surgical tool which is used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles identical to scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure. Free Sample Report + All Related Graphs & Charts @ : https://www.advancemarketanalytics.com/sample-report/1647-global-hemostatic-forceps-market Hemostatic Forceps Market Report offers a detailed overview of this market and discusses the dominant factors affecting the growth of the market. The impact of Porter's five armies on the market over the next few years has been discussed for a long time in this study. We will also forecast global market size and market outlook over the next few years. Types of Products, Applications and Hemostatic Forceps Market Report Geographical Scope taken as the Main Parameter for Market Analysis. This Research Report Conducts an assessment of the industry chain supporting this market. It also provides accurate information on various aspects of this market, such as production capacity, available production capacity utilization, industrial policies affecting the manufacturing chain and market growth. The Global Hemostatic Forceps Market segments and Market Data Break Down are illuminated below: by Type (Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps, Rochester-Carmalt hemostatic forceps), Application (Surgical, Dissection, Laparoscopic), End user (Hospitals, Multi-specialty clinics, Ambulatory surgical centers, Nursing homes, Others) What's Trending in Market: Use of Haemostatic forceps in trauma injury surgical procedures

Small Clinics creating a massive customer base as the hemostatic forceps are easy to use and does not require any technical expertise.

 Challenges: Stringent regulatory norms often discourage new manufacturers from exploring the market.

Reluctance by leading practitioners to switch from traditional practices to newly developed devices is a challenge faced by the market.

 Restraints: The cluttering of surgical field due to multiple clamp attachment causing inconvenience to the surgeons and leading to surgical errors is expected to hinder the market growth.

Market Growth Drivers: Increased volume of Surgical Procedures performed by the Doctors worldwide

The affordable price of the tools like forceps used to close the wounds

Growth in number of Hospitals and Surgical Centers

Rising Incidence of Haemostatic Injury Surgical Proced Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc. Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/1647-global-hemostatic-forceps-market Strategic Points Covered in Table of Content of Global Hemostatic Forceps Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Hemostatic Forceps market

Chapter 2: Exclusive Summary – the basic information of the Hemostatic Forceps Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Hemostatic Forceps

Chapter 4: Presenting the Hemostatic Forceps Market Factor Analysis, Post COVID Impact Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Hemostatic Forceps market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2026)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Hemostatic Forceps Market is a valuable source of guidance for individuals and companies in their decision framework. Data Sources & Methodology The primary sources involves the industry experts from the Global Hemostatic Forceps Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects. In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age. Get More Information: https://www.advancemarketanalytics.com/reports/1647-global-hemostatic-forceps-market What benefits does AMA research studies provides?

·        Supporting company financial and cash flow planning

·        Latest industry influencing trends and development scenario

·        Open up New Markets

·        To Seize powerful market opportunities

·        Key decision in planning and to further expand market share

·        Identify Key Business Segments, Market proposition & Gap Analysis

·        Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. About Author:

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies' revenues.

Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As. Contact Us:

Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 (206) 317 1218 sales@advancemarketanalytics.com   Connect with us at https://www.linkedin.com/company/advance-market-analytics https://www.facebook.com/AMA-Research-Media-LLP-344722399585916 https://twitter.com/amareport

[vmproducts]

Exterminator rochester ny

syracuse termite control

Any individual who lives in New York is accustomed to seeing bugs throughout the year. Be that as it may, it generally appears as the climate gets hotter and the blossoms start to sprout, the rodents and bugs are more predominant in your yard and home. Here is a rundown of the most well-known springtime bugs in New York. 

American and German Cockroaches 

On the off chance that you have lived in New York throughout the springtime, you have experienced cockroaches – maybe the most unwelcome house visitor in our fine state. The two most normal sorts in the region are American and German. They can just barely get through the littlest of openings looking for food and water. A great deal of the time individuals don't understand they have these springtime bothers until it has become an out-and-out pervasion. So regardless of whether you see only one this spring, deal with it before they duplicate. 

Ants 

Ants live in provinces and seldom travel alone, so in the event that you see a couple, there's very more where they came from. Family ants are in some cases hard to distinguish, yet once you do you can find the issue and fix it. They can be distinguished by size, shading, and movement time. Following their path back to the home is the initial phase in freeing your home of these vermin. Regular sorts to pay special mind to are fire ants, woodworker ants, and pharaoh ants. On the off chance that you can't choose which species is in your home or where their home is, at that point calling an expert is the best option. 

Mosquitos 

Most New Yorkies don't have issues with mosquitos in their home, however, arrive behind schedule spring their nibbles will cover your body. Mosquitos love the warm, sticky climate, so what preferred put over New York? In the event that your yard is seeing an invasion, attempt to dispose of any standing water or tall grass. To get the various kinds of mosquitoes far from you, generally keep an anti-agents splash around and fill a pail with sugar water, and put it in a far off area in your yard. They are pulled in to the sugar water and will not trouble you so much. 

Black rodent/Rooftop rodent 

Black rodents, otherwise called rooftop rodents, are exceptionally normal New York home irritations. The signs that they are in your house are droppings, pee smells, tracks, chewing openings, and sounds. The vast majority report hearing these critters in their lofts. On the off chance that your home has these nuisances, set out snares and lure to bait them in and dispose of them as fast as could be expected. 

Scorpions 

A great many people don't see scorpions until the spring since they rest in the colder time of year and come out as the air begins to warm. Springtime in New York is the ideal climate for scorpions to flourish. New Yorkies are accustomed to exhausting out their shoes in dread of a scorpion settling in them. Scorpions are excruciating and irritating, so on the off chance that they are disturbing your home call an expert to splash the border. 

Springtime vermin are undesirable however anticipated. As New Yorkies, we need to figure out how to distinguish them and dispose of them in the most ideal manners conceivable.

Call Town and Country Solutions for complete pest control and extermination services to get rid of any kind of pests from your properties. As a prominent Rochester Pest Control company, we ensure you that 100% safe & guaranteed extermination of pests.

[townandcountrysolutions]

Rochester Wildlife Control

[mosquitoshield78]

Effective Mosquito Control Rochester, MA with Mosquito Shield

Are pesky mosquitoes ruining your outdoor experience in Rochester, MA? Look no further than Mosquito Shield for the most effective mosquito control solution. Our team is dedicated to providing top-notch mosquito control services tailored to the unique needs of Rochester residents. With Mosquito Shield, you can reclaim your outdoor spaces and enjoy a mosquito-free environment. Our proven methods and advanced technologies ensure long-lasting protection, allowing you to savor the beauty of Rochester without the annoyance of mosquitoes. Say goodbye to itchy bites and hello to a more enjoyable outdoor lifestyle. Choose Mosquito Shield for reliable and efficient mosquito control in Rochester, MA, and experience the freedom to enjoy your outdoor spaces all season long.

[kashands]

MYCOPLASMA http://whale.to/m/scott7.html#A_Common_Disease_Agent_Weaponised_

The Linking Pathogen in Neurosystemic Diseases

Several strains of mycoplasma have been "engineered" to become more dangerous. They are now being blamed for AIDS, cancer, CFS, MS, CJD and other neurosystemic diseases.

Donald W. Scott MA, MSc. Ó 2001

Nexus Magazine Aug 2001

I - PATHOGENIC MYCOPLASMA

    A Common Disease Agent Weaponised

    How the Mycoplasma Works

II- CREATION OF THE MYCOPLASMA

    A Laboratory-Made Disease Agent

    Crystalline Brucella

    Crystalline Brucella and Multiple Sclerosis

    Contamination of Camp Detrick Lab Workers

III — COVERT TESTING OF MYCOPLASMA

    Testing the Dispersal Methods

    Testing via Mosquito Vector in Punta Gorda, Florida

    Testing via Mosquito Vector in Ontario

IV - COVERT TESTING OF OTHER DISEASE AGENTS

    Mad Cow Disease/Kuru/CJD in the Fore Tribe

    Testing Carcinogens over Winnipeg, Manitoba

V - BRUCELLA MYCOPLASMA AND DISEASE AIDS

    Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis

VI-TESTING FOR MYCOPLASMA IN YOUR BODY

    Polymerase Chain Reaction Test

    Blood Test

    ECG Test

    Blood Volume Test

VII- UNDOING THE DAMAGE

I - PATHOGENIC MYCOPLASMA

A Common Disease Agent Weaponised

There are 200 species of Mycoplasma. Most are innocuous and do no harm; only four or five are pathogenic. Mycoplasma fermentans (incognitus strain) probably comes from the nucleus of the Brucella bacterium. This disease agent is not a bacterium and not a virus; it is a mutated form of the Brucella bacterium, combined with a visna virus, from which the mycoplasma is extracted.

The pathogenic Mycoplasma used to be very innocuous, but biological warfare research conducted between 1942 and the present time has resulted in the creation of more deadly and infectious forms of Mycoplasma. Researchers extracted this mycoplasma from the Brucella bacterium and actually reduced the disease to a crystalline form. They "weaponised" it and tested it on an unsuspecting public in North America.

Dr Maurice Hilleman, chief virologist for the pharmaceutical company Merck Sharp & Dohme, stated that this disease agent is now carried by everybody in North America and possibly most people throughout the world.

Despite reporting flaws, there has clearly been an increased incidence of all the neuro/systemic degenerative diseases since World War II and especially since the 1970s with the arrival of previously unheard-of diseases like chronic fatigue syndrome and AIDS.

According to Dr Shyh-Ching Lo, senior researcher at The Armed Forces Institute of Pathology and one of America’s top mycoplasma researchers, this disease agent causes many illnesses including AIDS, cancer, chronic fatigue syndrome, Crohn’s colitis, Type I diabetes, multiple sclerosis, Parkinson’s disease, Wegener’s disease and collagen-vascular diseases such as rheumatoid arthritis and Alzheimer’s.

Dr Charles Engel, who is with the US National Institutes of Health, Bethesda, Maryland, stated the following at an NIH meeting on February 7, 2000: "I am now of the view that the probable cause of chronic fatigue syndrome and fibromyalgia is the mycoplasma..."

I have all the official documents to prove that mycoplasma is the disease agent in chronic fatigue syndrome/fibromyalgia as well as in AIDS, multiple sclerosis and many other illnesses. Of these, 80% are US or Canadian official government documents, and 20% are articles from peer-reviewed journals such as the Journal of the American Medical Association, New England Journal of Medicine and the Canadian Medical Association Journal. The journal articles and government documents complement each other.

How the Mycoplasma Works

The mycoplasma acts by entering into the individual cells of the body, depending upon your genetic predisposition.

You may develop neurological diseases if the pathogen destroys certain cells in your brain, or you may develop Crohn’s colitis if thepathogen invades and destroys cells in the lower bowel.

Once the mycoplasma gets into the cell, it can lie there doing nothing sometimes for 10, 20 or 30 years, but if a trauma occurs like an accident or a vaccination that doesn’t take, the mycoplasma can become triggered.

Because it is only the DNA particle of the bacterium, it doesn’t have any organelles to process its own nutrients, so it grows by uptaking pre-formed sterols from its host cell and it literally kills the cell; the cell ruptures and what is left gets dumped into the bloodstream.

II- CREATION OF THE MYCOPLASMA

A Laboratory-Made Disease Agent

Many doctors don’t know about this mycoplasma disease agent because it was developed by the US military in biological warfare experimentation and it was not made public. This pathogen was patented by the United States military and Dr Shyh-Ching Lo. I have a copy of the documented patent from the US Patent Office.(1)

All the countries at war were experimenting with biological weapons. In 1942, the governments of the United States, Canada and Britain entered into a secret agreement to create two types of biological weapons (one that would kill, and one that was disabling) for use in the war against Germany and Japan, who were also developing biological weapons. While they researched a number or disease pathogens, they primarily focused on the Brucella bacterium and began to weaponise it.

From its inception, the biowarfare program was characterised by continuing in-depth review and participation by the most eminent scientists, medical consultants, industrial experts and government officials, and it was classified Top Secret.

The US Public Health Service also closely followed the progress of biological warfare research and development from the very start of the program, and the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) in the United States were working with the military in weaponising these diseases. These are diseases that have existed for thousands of years, but they have been weaponised—which means they’ve been made more contagious and more effective. And they are spreading.

The Special Virus Cancer Program, created by the CIA and NIH to develop a deadly pathogen for which humanity had no natural immunity (AIDS), was disguised as a war on cancer but was actually part of MKNAOMI.2 Many members of the Senate and House of Representatives do not know what has been going on.  For example, the US Senate Committee on Government Reform had searched the archives in Washington and other places for the document titled "The Special Virus Cancer Program: Progress Report No. 8", and couldn’t find it. Somehow they heard I had it, called me and asked me to mail it to them. Imagine: a retired schoolteacher being called by the United States Senate and asked for one of their secret documents! The US Senate, through the Government Reform Committee, is trying to stop this type of government research.

Crystalline Brucella

The title page of a genuine US Senate Study, declassified on February 24, 1977, shows that George Merck, of the pharmaceutical company, Merck Sharp & Dohme (which now makes cures for diseases that at one time it created), reported in 1946 to the US Secretary of War that his researchers had managed "for the first time" to "isolate the disease agent in crystalline form".3

They had produced a crystalline bacterial toxin extracted from the Brucella bacterium. The bacterial toxin could be removed in crystalline form and stored, transported and deployed without deteriorating. It could be delivered by other vectors such as insects, aerosol or the food chain (in nature it is delivered within the bacterium). But the factor that is working in the Brucella is the mycoplasma.

Brucella is a disease agent that doesn’t kill people; it disables them. But, according to Dr Donald MacArthur of the Pentagon, appearing before a congressional committee in 1969,(4) researchers found that if they had mycoplasma at a certain strength—actually, 10 to the 10th power—it would develop into AIDS, and the person would die from it within a reasonable period of time because it could bypass the natural human defences.  If the strength was 10 to 8, the person would manifest with chronic fatigue syndrome or fibromyalgia. If it was l0 to 7, they would present as wasting; they wouldn’t die and they wouldn’t be disabled, but they would not be very interested in life; they would waste away.

Most of us have never heard of the disease brucellosis because it largely disappeared when they began pasteurising milk, which was the carrier. One salt shaker of the pure disease agent in a crystalline form could sicken the entire population of Canada. It is absolutely deadly, not so much in terms of killing the body but disabling it.

Because the crystalline disease agent goes into solution in the blood, ordinary blood and tissue tests will not reveal its presence. The mycoplasma will only crystallise at 8.1 pH, and the blood has a pH of 7.4 pH. So the doctor thinks your complaint is "all in your head".

Crystalline Brucella and Multiple Sclerosis

In 1998 in Rochester, New York, I met a former military man, PFC Donald Bentley, who gave me a document and told me: "I was in the US Army, and I was trained in bacteriological warfare. We were handling a bomb filled with brucellosis, only it wasn’t brucellosis; it was a Brucella toxin in crystalline form. We were spraying it on the Chinese and North Koreans."

He showed me his certificate listing his training in chemical, biological and radiological warfare. Then he showed me 16 pages of documents given to him by the US military when he was discharged from the service. They linked brucellosis with multiple sclerosis, and stated in one section: "Veterans with multiple sclerosis, a kind of creeping paralysis developing to a degree of 10% or more disability within two years after separation from active service, may be presumed to be service-connected for disability compensation. Compensation is payable to eligible veterans whose disabilities are due to service." In other words: "If you become ill with multiple sclerosis, it is because you were handling this Brucella, and we will give you a pension. Don’t go raising any fuss about it." In these documents, the government of the United States revealed evidence of the cause of multiple sclerosis, but they didn’t make it known to the public—or to your doctor.

In a 1949 report, Drs Kyger and Haden suggested "the possibility that multiple sclerosis might be a central nervous system manifestation of chronic brucellosis". Testing approximately 113 MS patients, they found that almost 95% also tested positive for Brucella.(5) We have a document from a medical journal, which concludes that one out of 500 people who had brucellosis would develop what they call neurobrucellosis; in other words, brucellosis in the brain, where the Brucella settles in the lateral ventrides—where the disease multiple sclerosis is basically located.6

Contamination of Camp Detrick Lab Workers

A 1948 New England Journal of Medicine report titled "Acute Brucellosis Among Laboratory Workers" shows us how actively dangerous this agent is.7   The laboratory workers were from Camp Detrick, Frederick, Maryland, where they were developing biological weapons. Even though these workers had been vaccinated, wore rubberised suits and masks and worked through holes in the compartment, many of them came down with this awful disease because it is so absolutely and terrifyingly infectious.

The article was written by Lt Calderone Howell, Marine Corps Captain Edward Miller, Marine Corps, Lt Emily Kelly, United States Naval Reserve; and Captain Henry Bookman. They were all military personnel engaged in making the disease agent Brucella into a more effective biological weapon

III — COVERT TESTING OF MYCOPLASMA

Testing the Dispersal Methods

Documented evidence proves that the biological weapons they were developing were tested on the public in various communities without their knowledge or consent.

The government knew that crystalline Brucella would cause disease in humans. Now they needed to determine how it would spread and the best way to disperse it. They tested dispersal methods for Brucella suis and Brucella melitensis at Dugway Proving Ground, Utah, in June and September 1952. Probably, 100% of us now are infected with Brucella suis and Brucella melitensis.(8)

Another government document recommended the genesis of open-air vulnerability tests and covert research and development programs to be conducted by the Army and supported by the Central Intelligence Agency.

At that time, the Government of Canada was asked by the US Government to cooperate in testing weaponised Brucella, and Canada cooperated fully with the United States. The US Government wanted to determine whether mosquitoes would carry the disease and also if the air would carry it. A government report stated that "open-air testing of infectious biological agents is considered essential to an ultimate understanding of biological warfare potentialities because of the many unknown factors affecting the degradation of micro-organisms in the atmosphere".9

Testing via Mosquito Vector in Punta Gorda, Florida

A report from The New England Journal of Medicine reveals that one of the first outbreaks of chronic fatigue syndrome was in Punta Gorda, Florida, back in 1957.(10)   It was a strange coincidence that a week before these people came down with chronic fatigue syndrome, there was a huge influx of mosquitoes.

The National Institutes of Health claimed that the mosquitoes came from a forest fire 30 miles away. The truth is that those mosquitoes were infected in Canada by Dr Guilford B. Reed at Queen’s University. They were bred in Belleville, Ontario, and taken down to Punta Gorda and released there.

Within a week, the first five cases ever of chronic fatigue syndrome were reported to the local clinic in Punta Gorda. The cases kept coming until finally 450 people were ill with the disease.

Testing via Mosquito Vector in Ontario

The Government of Canada had established the Dominion Parasite Laboratory in Belleville, Ontario, where it raised 100 million mosquitoes a month. These were shipped to Queen’s University and certain other facilities to be infected with this crystalline disease agent The mosquitoes were then let loose in certain communities in the middle of the night, so that the researchers could determine how many people would become ill with chronic fatigue syndrome or fibromyalgia, which was the first disease to show.

One of the communities they tested it on was the St Lawrence Seaway valley, all the way from Kingston to Cornwall, in 1984. They let out hundreds of millions of infected mosquitoes. Over 700 people in the next four or five weeks developed myalgic encephalomyelitis, or chronic fatigue syndrome.

IV - COVERT TESTING OF OTHER DISEASE AGENTS

Mad Cow Disease/Kuru/CJD in the Fore Tribe

Before and during World War II, at the infamous Camp 731 in Manchuria, the Japanese military contaminated prisoners of war with certain disease agents.

They also established a research camp in New Guinea in 1942. There they experimented upon the Fore Indian tribe and inoculated them with a minced-up version of the brains of diseased sheep containing the visna virus which causes "mad cow disease" or Creutzfeldt—Jakob disease.

About five or six years later, after the Japanese had been driven out, the poor people of the Fore tribe developed what they called kuru, which was their word for "wasting", and they began to shake, lose their appetites and die. The autopsies revealed that their brains had literally turned to mush. They had contracted "mad cow disease" from the Japanese experiments.

When World War II ended, Dr Ishii Shiro—the medical doctor who was commissioned as a General in the Japanese Army so he could take command of Japan’s biological warfare development, testing and deployment—was captured. He was given the choice of a job with the United States Army or execution as a war criminal. Not surprisingly, Dr Ishii Shiro chose to work with the US military to demonstrate how the Japanese had created mad cow disease in the Fore Indian tribe.

In 1957, when the disease was beginning to blossom in full among the Fore people, Dr Carleton Gajdusek of the US National Institutes of Health headed to New Guinea to determine how the minced-up brains of the visna-infected sheep affected them. He spent a couple of years there, studying the Fore people, and wrote an extensive report. He won the Nobel Prize for "discovering" kuru disease in the Fore tribe.

Testing Carcinogens over Winnipeg, Manitoba

In 1953, the US Government asked the Canadian Government if it could test a chemical over the city of Winnipeg. It was a big city with 500,000 people, miles from anywhere. The American military sprayed this carcinogenic chemical in a 1,000%-attenuated form, which they said would be so watered down that nobody would get very sick; however, if people came to clinics with a sniffle, a sore throat or ringing in their ears, the researchers would be able to determine what percentage would have developed cancer if the chemical had been used at full strength.

We located evidence that the Americans had indeed tested this carcinogenic chemical—zinc cadmium sulphide—over Winnipeg in 1953. We wrote to the Government of Canada, explaining that we had solid evidence of the spraying and asking that we be informed as to how high up in the government the request for permission to spray had gone. We did not receive a reply.

Shortly after, the Pentagon held a press conference on May 14, 1997, where they admitted what they had done. Robert Russo, writing for the Toronto Star11 from Washington, DC, reported the Pentagon’s admission that in 1953 it had obtained permission from the Canadian Government to fly over the city of Winnipeg and spray out this chemical—which sifted down on kids going to school, housewives hanging out their laundry and people going to work. US Army planes and trucks released the chemical 36 times between July and August 1953. The Pentagon got its statistics, which indicated that if the chemical released had been full strength, approximately a third of the population of Winnipeg would have developed cancers over the next five years.

One professor, Dr Hugh Fudenberg, MD, twice nominated for the Nobel Prize, wrote a magazine article stating that the Pentagon came clean on this because two researchers in Sudbury, Ontario—Don Scott and his son, Bill Scott—had been revealing this to the public. However, the legwork was done by other researchers!

The US Army actually conducted a series of simulated germ warfare tests over Winnipeg. The Pentagon lied about the tests to the mayor, saying that they were testing a chemical fog over the city, which would protect Winnipeg in the event of a nuclear attack.

A report commissioned by US Congress, chaired by Dr Rogene Henderson, lists 32 American towns and cities used as test sites as well.

V - BRUCELLA MYCOPLASMA AND DISEASE AIDS

The AIDS pathogen was created out of a Brucella bacterium mutated with a visna virus; then the toxin was removed as a DNA particle called a mycoplasma. They used the same mycoplasma to develop disabling diseases like MS, Crohn’s colitis, Lyme disease, etc.

In the previously mentioned US congressional document of a meeting held on June 9, 1969, (12) the Pentagon delivered a report to Congress about biological weapons. The Pentagon stated: "We are continuing to develop disabling weapons." Dr MacArthur, who was in charge of the research, said: "We are developing a new lethal weapon, a synthetic biological agent that does not naturally exist, and for which no natural immunity could have been acquired."

Think about it. If you have a deficiency of acquired immunity, you have an acquired immunity deficiency. Plain as that. AIDS.

In laboratories throughout the United States and in a certain number in Canada including at the University of Alberta. the US Government provided the leadership for the development of AIDS for the purpose of population control. After the scientists had perfected it, the government sent medical teams from the Centers for Disease Control-under the direction of Dr Donald A. Henderson, their investigator into the 1957 chronic fatigue epidemic in Punta Gorda—during 1969 to 1971 to Africa and some countries such as India, Nepal and Pakistan where they thought the population was becoming too large.13 They gave them all a free vaccination against smallpox; but five years after receiving this vaccination, 60% of those inoculated were suffering from AIDS. They tried to blame it on a monkey, which is nonsense.

A professor at the University of Arkansas made the claim that while studying the tissues of a dead chimpanzee she found traces of HIV. The chimpanzee that she had tested was born in the United States 23 years earlier. It had lived its entire life in a US military laboratory where it was used as an experimental animal in the development of these diseases. When it died, its body was shipped to a storage place where it was deep-frozen and stored in case they wanted to analyse it later. Then they decided that they didn’t have enough space for it, so they said, "Anybody want this dead chimpanzee?" and this researcher from Arkansas said: "Yes. Send it down to the University of Arkansas. We are happy to get anything we can get." They shipped it down and she found HIV in it. That virus was acquired by that chimpanzee in the laboratories where it was tested.14

Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis

Chronic fatigue syndrome is more accurately called myalgic encephalomyelitis. The chronic fatigue syndrome nomenclature was given by the US National Institutes of Health because it wanted to downgrade and belittle the disease.

An MRI scan of the brain of a teenage girl with chronic fatigue syndrome displayed a great many scars or punctate lesions in the left frontal lobe area where portions of the brain had literally dissolved and been replaced by scar tissue. This caused cognitive impairment, memory impairment, etc. And what was the cause of the scarring? The mycoplasma. So there is very concrete physical evidence of these tragic diseases, even though doctors continue to say they don’t know where it comes from or what they can do about it.

Many people with chronic fatigue syndrome, myalgic encephalo-myelitis and fibromyalgia who apply to the Canada Pensions Plan Review Tribunal will be turned down because they cannot prove that they are ill. During 1999 I conducted several appeals to Canada Pensions and the Workers Compensation Board (WCB, now the Workplace Safety and Insurance Board) on behalf of people who have been turned down. I provided documented evidence of these illnesses, and these people were all granted their pensions on the basis of the evidence that I provided.

In March 1999, for example, I appealed to the WCB on behalf of a lady with flbromya1gia who had been, denied her pension back in 1993. The vice-chairman of the board came to Sudbury to hear the appeal, and I showed him a number of documents which proved that this lady was physically ill with fibromyalgia. It was a disease that caused physical damage, and the disease agent was a mycoplasma. The guy listened for three hours, and then he said to me: "Mr Scott, how is it I have never heard of any of this before? I said: "We brought a top authority in this area into Sudbury to speak on this subject and not a single solitary doctor came to that presentation."

VI-TESTING FOR MYCOPLASMA IN YOUR BODY

Polymerase Chain Reaction Test

Information is not generally available about this agent because, first of all, the mycoplasma is such a minutely small disease agent. A hundred years ago, certain medical theoreticians conceived that there must be a form or disease agent smaller than bacteria and viruses. This pathogenic organism, the mycoplasma, is so minute that normal blood and tissue tests will not reveal its presence as the source of the disease.

Your doctor may diagnose you with Alzheimer’s disease, and he will say:

"Golly, we don’t know where Alzheimer’s comes from. All we know is that your brain begins to deteriorate, cells rupture, the myelin sheath around the nerves dissolves, and so on." Or if you have chronic fatigue syndrome, the doctor will not be able to find any cause for your illness with ordinary blood and tissue tests.

This mycoplasma couldn’t be detected until about 30 years ago when the polymerase chain reaction (PCR) test was developed, in which a sample of your blood is examined and damaged particles are removed and subjected to a polymerase chain reaction. This causes the DNA in the particles to break down. The particles are then placed in a nutrient, which causes the DNA to grow back into its original form. If enough of the substance is produced, the form can be recognised, so it can be determined whether Brucella or another kind of agent is behind that particular mycoplasma.

Blood Test

If you or anybody in your family has myalgic encephalomyelitis, fibromyalgia, multiple sclerosis or Alzheimer’s, you can send a blood sample to Dr Les Simpson in New Zealand for testing.

If you are ill with these diseases, your red blood cells will not be normal doughnut-shaped blood cells capable of being compressed and squeezed through the capillaries, but will swell up like cherry-filled doughnuts which cannot be compressed. The blood cells become enlarged and distended because the only way the mycoplasma can exist is by uptaking pre-formed sterols from the host cell. One of the best sources of pre-formed sterols is cholesterol, and cholesterol is what gives your blood cells flexibility. If the cholesterol is taken out by the mycoplasma, the red blood cell swells up and doesn’t go through, and the person begins to feel all the aches and pains and all the damage it causes to the brain, the heart, the stomach, the feet and the whole body because blood and oxygen are cut off.

And that is why people with fibromyalgia and chronic fatigue syndrome have such a terrible time. When the blood is cut off from the brain, punctate lesions appear because those parts of the brain die. The mycoplasma will get into portions of the heart muscle, especially the left ventricle, and those cells will die. Certain people have cells in the lateral ventricles of the brain that have a genetic predisposition to admit the mycoplasma, and this causes the lateral ventricles to deteriorate and die. This leads to multiple sclerosis, which will progress until these people are totally disabled; frequently, they die prematurely. The mycoplasma will get into the lower bowel, parts of which will die, thus causing colitis. All of these diseases are caused by the degenerating properties of the mycoplasma.

In early 2000, a gentleman in Sudbury phoned me and told me he had fibromyalgia. He applied for a pension and was turned down because his doctor said it was all in his head and there was no external evidence. I gave him the proper form and a vial, and he sent his blood to Dr Simpson to be tested. He did this with his family doctor’s approval, and the results from Dr Simpson showed that only 4% of his red blood cells were functioning normally and carrying the appropriate amount of oxygen to his poor body, whereas 83% were distended, enlarged and hardened, and wouldn’t go through the capillaries without an awful lot of pressure and trouble. This is the physical evidence of the damage that is done.

ECG Test

You can also ask your doctor to give you a 24-hour Holter ECG. You know, of course, that an electrocardiogram is a measure of your heartbeat and shows what is going on in the right ventricle, the left ventricle and so on. Tests show that 100% of patients with chronic fatigue syndrome and fibromyalgia have an irregular heartbeat. At various periods during the 24 hours, the heart, instead of working happily away going "bump-BUMP, bump-BUMP", every now and again goes "buhbuhbuhbuhbubbuhbuhbuhbuh". The T-wave (the waves are called P, Q, R, S and T) is normally a peak, and then the wave levels off and starts with the P-wave again. In chronic fatigue and fibromyalgia patients, the T-wave flattens off, or actually inverts. That means the blood in the left ventricle is not being squeezed up through the aorta and around through the body.

My client from Sudbury had this test done and, lo and behold, the results stated: "The shape of T and S-T suggests left ventricle strain pattern, although voltage and so on is normal." The doctor had no clue as to why the T-wave was not working properly. I analysed the report of this patient who had been turned down by Canada Pensions and sent it back to them. They wrote back, saying: "It looks like we may have made a mistake. We are going to give you a hearing and you can explain this to us in more detail."

So it is not all in your imagination. There is actual physical damage to the heart. The left ventricle muscles do show scarring.

That is way many people are diagnosed with a heart condition when they first develop fibromyalgia, but it’s only one of several problems because the mycoplasma can do all kinds of damage.

Blood Volume Test

You can also ask your doctor for a blood volume test. Every human being requires a certain amount of blood per pound of body weight, and it has been observed that people with fibromyalgia, chronic fatigue syndrome, multiple sclerosis and other illnesses do not have the normal blood volume their body needs to function properly. Doctors aren’t normally aware of this.

This test measures the amount of blood in the human body by taking out 5 cc, putting a tracer in it and then putting it back into the body. One hour later, take out 5 cc again and look for the tracer. The thicker the blood and the lower the blood volume, the more tracer you will find.

The analysis of one of my clients stated: "This patient was referred for red cell mass study. The red cell volume is 16.9 ml per kg of body weight. The normal range is 25 to 35 ml per kg. This guy has 36% less blood in his body than the body needs to function." And the doctor hadn’t even known the test existed.

If you lost 36% of your blood in an accident, do you think your doctor would tell you that you are allright and should just take up line dancing and get over it? They would rush you to the nearest hospital and start transfusing you with blood. These tragic people with these awful diseases are functioning with anywhere from 7% to 50% less blood than their body needs to function.

VII- UNDOING THE DAMAGE

The body undoes the damage itself. The scarring in the brain of people with chronic fatigue and fibromyalgia will be repaired. There is cellular repair going on all the time. But the mycoplasma has moved on to the next cell.

In the early stages of a disease, doxycydine may reverse that disease process. It is one of the tetracycline antibiotics, but it is not bactericidal; it is bacteriostatic—it stops the growth of the mycoplasma. And if the mycoplasma growth can be stopped for long enough, then the immune system takes over.

Doxycycline treatment is discussed in a paper by mycoplasma expert Professor Garth Nicholson, PhD, of the Institute for Molecular Medicine." Dr Nicholson is involved in a US$8 million mycoplasma research program funded by the US military and headed by Dr Charles Engel of the NIH. The program is studying Gulf War veterans, 450 of them, because there is evidence to suggest that Gulf War syndrome is another illness (or set of illnesses) caused by mycoplasma.

 Endnotes

1. "Pathogenic Mycoplasma", US Patent No. 5,242,820, issued September 7, 1993. Dr Lo is listed as the Inventor" and the American Registry of Pathology, Washington, DC, is listed as the "Assignee".

2. "Special Virus Cancer Program: Progress Report No. 8", prepared by the National Cancer Institute, Viral Oncology, Etiology Area, July 1971, submitted to NIH Annual Report in May 1971 and updated July 1971.

3. US Senate, Ninety-fifth Congress, Hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, Biological Testing Involving Human Subjects by the Department of Defense, 1977; released as US Army Activities in the US Biological Warfare Programs, Volumes One and Two, 24 February 1977.

4. Dr Donald MacArthur, Pentagon, Department of Defense Appropriations for 1970, Hearings before Subcommittee of the Committee on Appropriations, House of Representatives, Ninety-First Congress, First Session, Monday June 9, 1969, pp 105—144, esp. pp. 114, 129.

5. Kyger, E. R. and Russell L. Haden, "Brucellosis and Multiple Sclerosis", The American journal of Medical Sciences 1949:689-693.

6. Colmonero et al., "Complications Associated with Brucella melitensis Infection: A Study of 530 Cases", Medicine 1996;75(4).

7. Howell, Miller, Kelly and Bookman, "Acute Brucellosis Among Laboratory Workers", New England Journal of Medicine 1948;236:741.

8. "Special Virus Cancer Program: Progress Report No. 8", ibid., table 4, p. 135.

9. US Senate, Hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, March 8 and May 23, 1977, ibid.

10. New England journal of Medicine, August 22, 1957, p. 362.

11. Toronto Star, May 15, 1997.

12. Dr Donald MacArthur, Pentagon, Department of Defense Appropriations for 1970, Hearings, Monday June 9, 1969, ibid., p.129.

13. Henderson, Donald A., "Smallpox: Epitaph for a Killer", National Geographic, December 1978, p. 804.

14. Blum, Deborah, The Monkey Wars, Oxford University Press, New York, 1994.

15. Nicholson, G. 1., "Doxycycline treatment and Desert Storm", JAMA 1995;273:61 8-619.

Recommended Reading

•Horowitz, Leonard, Emerging Viruses: Aids and Ebola, Tetrahedron Publishing, USA, 1996.

• Johnson, Hillary, Osler’s Web, Crown Publishers, New York, 1996.

• Scott, Donald W. and William L. C. Scott, The Brucellosis Triangle, The Chelmsford Publishers (Box 133, Stat. B., Sudbury, Ontario P3E 4N5), Canada, 1998 (US$21.95 + $3 s&h in US).

• Scott, Donald W. and William 1. C. Scott, The Extremely Unfortunate Skull Valley Incident, The Chelmsford Publishers, Canada, 1996 (revised, extended edition available from mid-September 2001; US$16.00 pre-pub. Price + US$3 s&h in US).

•The journal of Degenerative Diseases (Donald W. Scott, Editor), The Common Cause Medical Research Foundation (Box 133, Stat B., Sudbury, Ontario, P3E 4N5), Canada (quarterly journal; annual subscription: US$25.00 in USA, $30 foreign).

Additional Contacts

• Ms Jennie Burke, Australian Biologics, Level 6, 383 Pitt Street, Sydney NSW 2000, Australia tel +61 (0)2 9283 0807, fax +61 (0)2 9283 0910. Australian Biologics does tests for mycoplasma.

• Consumer Health Organization of Canada, 1220 Sheppard Avenue East #412, Toronto, Ontario, Canada M2K 255, tel +1 (416)490 0986, website www.consumerhealth.org/.

• Professor Garth Nicholson, PhD, Institute for Molecular Medicine, 15162 Triton Lane, Huntington Beach, CA, 92649-1401, USA, tel +1(714) 903 2900.

• Dr Les Simpson, Red Blood Cell Research Ltd, 31 Bath Street, Dunedin, 9001, New Zealand, tel +64 (0)3 471 8540, email rbc.research.limited@xtra.co.nz . (Note: Dr Simpson directs his study to red cell shape analysis, not the mycoplasrna hypothesis.)

• The Mycoplasma Registry for Gulf War Illness, S. & 1. Dudley, 303 47th St, J-10 San Diego, CA 92102-5961, tel/fax +1(619) 266 1116, fax (619) 266 1116, email mycoreg@juno.com.

About the Author

Donald Scott, MA, MSc, is a retired high school teacher and university professor. He is also a veteran of WWII and was awarded the North Atlantic Star, the Burma Star with Clasp, the 1939—1945 Volunteer Service Medal and the Victory Medal. He is currently President of The Common Cause Medical Research Foundation, a not-for-profit organisation devoted to research into neurosystemic degenerative diseases. He is also Adjunct Professor with the Institute for Molecular Medicine and he produces and edits the journal of Degenerative Diseases. He has extensively researched neurosystemic degenerative diseases over the past five years and has authored many documents on the relationship between degenerative diseases and a pathogenic mycoplasma called Mycoplasma fermentans. His research is based upon solid government evidence.

You may contact Donald Scott at: 190 Mountain St., Ste. 405, Sudbury, Ontario, Canada P3B 4G2. 705-670-0180.

Note: Dr. David Webster at Sudbury General Hospital, a wonderful person, with whom I have had conversations about these awful diseases can tell your doctor about the Blood Volume test.

 http://whale.to/m/scott7.html#A_Common_Disease_Agent_Weaponised_

[Home]  [Mycoplasma]

[healthcare00897]

Hemostats Market To Witness Significant Growth By 2026

Hemostats, also referred to as hemostatic clamp, arterial forceps or pean are surgical tools used in surgical procedures to control bleeding. The hemostats were designed to clamp blood vessels of small size to manage blood flow in hemorrhagic cases. These devices are also used to grasp and secure superficial fascia during wound closure surgical procedures. The hemostats, with hinges and rings, are visibly similar to scissors. These instruments have a locking mechanism known as rachet that is used for clamping wherein the jaws of locking forceps come together, which helps in sealing the opening of the blood vessels. In many cases, the hemostats can be used to hold the subcutaneous tissues on the edges of the wound, while the tissue forceps are applied to the other edge to retract and gain better exposure to the wound site. Hemostats serve as an excellent tool to visualize, expose, and investigate deeper tissue areas in case of patients with serious injuries. The hemostats securely holds blood vessels and other tubular structures to obstruct the blood or fluid flow in damaged vessels. It is available in various sizes and patterns depending on the requirement of the application. The use of hemostats is expanding gradually, as uncontrolled bleeding in the surgical trauma settings frequently result into significant clinical and economic impact that can even lead to loss of life.

Global Hemostats Market Regional Insights

On the basis of region, the global hemostats market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global hemostats market, owing to large number of surgeries performed in the region as well as development of technologically advanced products for achieving blood control during trauma management procedures. According to the National Health Statistics Report by the Centers of Disease Control & Prevention, around 201,748.3 million surgical and non-surgical procedures were performed in the U.S. in 2011. The data also suggests that 28.6 million visits to ambulatory surgery cases were reported in the U.S.

Furthermore, Asia Pacific is expected to gain significant traction in the global hemostats market in the near future. Marginal market share would be grasped by the local players entering into the market due to less stringent regulatory requirements for manufacturing of these instruments and growing customer pool due to rapid development of healthcare infrastructure in various economies of Asia Pacific. For instance, Tonglu BA Medical Devices Co., Ltd and Suzhou Texnet Commerce Co., Ltd are China-based hemostat manufacturing companies that offers similar surgical hemostats to that of the major international players at significantly lower costs. The increasing entry of new players into the market is thus, responsible for faster growth of Asia Pacific region in the global hemostats market.

Global Hemostats Market Competitive Analysis

Key players operating in the global hemostats market include B.Braun Melsungen AG, CareFusion Corporation, Pentax Medical, Shanghai Medical Instruments, Teleflex Medical, Asa Dental, J & J Instruments, and others.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1598

Global Hemostats Market Taxonomy:

On the basis of instrument type:

   • Halstead mosquito hemostatic forceps

   • Kelly and Crile hemostatic forceps

   • Rochester-Carmalt hemostatic forceps

On the basis of end user:

   • Hospitals

   • Multi-specialty clinics

   • Ambulatory surgical centers

   • Nursing homes

   • Others

On the basis of region:

   • North America

   • Europe

   • Asia Pacific

   • Latin America

   • Africa

   • Middle East

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

[medicaldevicetech]

Hemostats Market 2019 Important Research, Hemostats Market Trends and Development 2023

Market Highlights

Hemostasis is the course of blood clotting. Blood clotting plays a vital role in various surgeries by achieving positive outcomes with the reduction of blood loss. This clotting process reduces the surgery time and the need for blood transfusion. Thus, hemostats are surgical instruments used to regulate the bleeding during surgery. Hemostats are also used for oozing out venomous bleeds, bone bleeding, and others. The scope of hemostats is growing rapidly with technological advancements and a growing number of surgeries. Also, growth in a number of hospitals and healthcare facilities, and initiatives taken by the government are the major factors driving the growth of the hemostats market.

The hemostats market is expected to grow at a CAGR of 6.4%.

Free Sample copy Available @ https://www.marketresearchfuture.com/sample_request/6413

However, the high cost of hemostats, government’s rules and regulations and lack of skilled professionals is expected to hamper the growth of hemostats market.

Segmentation

The global hemostats market has been segmented on the basis of product type, instrument type, application, and end-user.

On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants.  On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps. On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others.

Regional Analysis

The Americas is projected to lead the hemostats market in the forecast period. Rising rate in a number of diseases due to various factors such as a change in lifestyle, rising geriatric population and others contribute majorly to the growth of the market. Increasing healthcare awareness, advancement in technology, medical tourism, and an increase in disposable income are some other factors that boost the growth of the market.  According to the United States Center for Disease Control and Prevention, around 45% of the American population is suffering from at least one chronic condition demanding critical care.

The European market is expected to hold the second largest market share. Introduction of technologically advanced hemostat products such as FLOSEAL, HEMOPATCH, and TISEEL is projected to boost the demand for these products in the European market. The European hemostats market is anticipated to be driven due to the increase in the elderly aged population, which is expected to ultimately lead to a higher number of surgeries. The European market is projected to grow because of the increase in elderly population, growing prevalence of diabetes, and heart rhythm problems in the region.

Asia-Pacific was projected to be the fastest growing region for the global hemostats market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Access Report @ https://www.marketresearchfuture.com/reports/hemostats-market-6413

Key Players

Some of the key players in the global hemostats market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation (US).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

[buggcontrol]

bee removal rochester ny - buggcontrol.com

Bugg Control, Inc. is your Rochester NY, and Buffalo bee exterminator. Our bug exterminator specializes in providing quality bee control and can also help rid you of wasps, hornets, mosquitoes, and other flying insects. Call us today to schedule your service. Visit https://buggcontrol.com/bee-control/ for more information.

[townandcountrysolutions]

Mosquito control syracuse

[townandcountrysolutions]

Bat Control Buffalo | Pest Control Rochester